Evidence map›Paper›PMID 34801843›Full record

SynthesisPublic health2021

Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention.

H Knight, R Jia, K Ayling, K Bradbury, K Baker, T Chalder, J R Morling, L Durrant, T Avery, J K Ball and 4 more

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Journal of preventive medicine and hygiene · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Strengthening scientific credibility against misinformation and disinformation: Where do we stand now?Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  18. Article
  19. Article
  20. Interventions to increase COVID-19 vaccine uptake: a scoping review.The Cochrane database of systematic reviews · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

H KnightUniversity of Nottingham, School of Medicine, Nottingham, UK.
R JiaUniversity of Nottingham, School of Medicine, Nottingham, UK.
K AylingUniversity of Nottingham, School of Medicine, Nottingham, UK.
K BradburyNational Institute for Health Research (NIHR) ARC Wessex, UK; University of Southampton, Department of Psychology, Southampton, UK.
K BakerNational Institute for Health Research (NIHR) ARC Wessex, UK.
T ChalderKings College London, Department of Psychological Medicine, London, UK.
J R MorlingUniversity of Nottingham, School of Medicine, Nottingham, UK; National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
L DurrantUniversity of Nottingham, School of Medicine, Nottingham, UK.
T AveryUniversity of Nottingham, School of Medicine, Nottingham, UK.
J K BallUniversity of Nottingham, School of Life Sciences, Nottingham, UK.
C BarkerNational Institute for Health Research (NIHR) ARC Wessex, UK.
R BennettRehab Studio LTD, London, UK.
T McKeeverUniversity of Nottingham, School of Medicine, Nottingham, UK.
K VedharaUniversity of Nottingham, School of Medicine, Nottingham, UK. Electronic address: kavita.vedhara@nottingham.ac.uk.
University of Nottingham · GBNational Institute for Health Research · GBKing's College London · GBNottingham University Hospitals NHS Trust · GB

Funding

Medical Research Council MR/P008348/1
6 · The paper itself

Abstract

objectivesSevere Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75-90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. STUDY

design& Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. DISCUSSION: The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesHumansSARS-CoV-2VaccinationVaccination HesitancyCOVID-19 VaccinesVaccinesCOVID-19InterventionMotivational interviewingVaccine hesitancy

Identifiers

PMID34801843
PMCPMC8520885
OpenAlexW3205567968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.